Your browser doesn't support javascript.
loading
Management of chronic kidney disease: a Hong Kong consensus recommendation.
Tang, S C W; Ho, K K L; Ko, W W K; Lee, A; Leung, C B; Lo, W K; Ma, R C W; Pang, S L; Tan, K C B; Tsang, M W; Wong, M C S; Wong, W C W; Wong, F K M; Szeto, C C.
Affiliation
  • Tang SCW; Division of Nephrology, Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China.
  • Ho KKL; Department of Nephrology, Virtus Medical Group, Hong Kong SAR, China.
  • Ko WWK; Department of Family Medicine and Primary Healthcare, Queen Mary Hospital, Hong Kong SAR, China.
  • Lee A; The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Leung CB; Central Administration Office, Hong Kong Baptist Hospital, Hong Kong SAR, China.
  • Lo WK; Private Practice, Hong Kong SAR, China.
  • Ma RCW; Division of Endocrinology and Diabetes, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.
  • Pang SL; Private Practice, Hong Kong SAR, China.
  • Tan KCB; Division of Endocrinology and Metabolism, Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China.
  • Tsang MW; United Medical Practice, Hong Kong SAR, China.
  • Wong MCS; The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Wong WCW; Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Wong FKM; Private Practice, Hong Kong SAR, China.
  • Szeto CC; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.
Hong Kong Med J ; 2024 Aug 27.
Article in En | MEDLINE | ID: mdl-39188163
ABSTRACT
Chronic kidney disease (CKD) imposes a significant burden on healthcare systems worldwide, and diabetes is a major risk factor for CKD. There is currently no consensus in Hong Kong regarding the prioritisation of early identification and intervention for CKD. A comprehensive and Hong Kong-specific diabetes and CKD treatment guideline is also lacking. A multidisciplinary group of experts discussed issues surrounding the current management of CKD and reviewed evidence in the context of local experience to support recommendations. The experts used a modified Delphi approach to finalise recommendations. Consensus was regarded as ≥75% acceptability among all expert panel members. The panel members finalised 14 CKD-focused consensus statements addressing disease definition, screening, disease monitoring, lifestyle management, and treatment strategies. The recommendations provided are relevant to the Hong Kong healthcare setting and can be used as a guide by physicians across various specialties to facilitate the appropriate management of CKD.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hong Kong Med J Journal subject: MEDICINA Year: 2024 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hong Kong Med J Journal subject: MEDICINA Year: 2024 Document type: Article Affiliation country: China